铜陵洁雅生物科技股份有限公司董事会 关于独立董事独立性自查情况的专项报告 根据证监会《上市公司独立董事管理办法》《深圳证券交易所股票上市规则》 《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司规范运作》 等要求，铜陵洁雅生物科技股份有限公司（以下简称"公司"）董事会，就公司 在任独立董事何文龙、赵波、陈彦的独立性情况进行评估并出具如下专项意见： 经核查，独立董事何文龙、赵波、陈彦的任职经历以及签署的相关自查文件， 上述人员未在公司担任除独立董事以外的任何职务，也未在公司主要股东公司担 任任何职务，与公司以及主要股东之间不存在利害关系或其他可能妨碍其进行独 立客观判断的关系，因此，公司独立董事符合《上市公司独立董事管理办法》《深 圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司规范运作》中对 独立董事独立性的相关要求。 铜陵洁雅生物科技股份有限公司 2025 年 4 月 23 日 ...

铜陵洁雅生物科技股份有限公司 铜陵洁雅生物科技股份有限公司 2024 年度独立董事述职报告 （独立董事：陈彦） 各位股东及股东代表： 本人作为铜陵洁雅生物科技股份有限公司（以下简称"公司"）第五届董事 会的独立董事， 严格按照《中华人民共和国公司法》《中华人民共和国证券法》 《上市公司独立董事管理办法》《深圳证券交易所创业板股票上市规则》《深圳 证券交易所上市公司自律监管指引第 2 号——创业板上市公司规范运作》等相关 法律法规及《公司章程》《公司独立董事工作制度》的规定和要求，忠实履行独 立董事的职责，履行诚信勤勉义务，始终站在独立公正的立场参与公司决策，充 分发挥独立董事的作用，积极促进公司健全内控制度及规范运作，维护公司全体 股东尤其是中小股东的合法利益。 现将本人 2024 年度履行独立董事职责的工作情况报告如下： 一、独立董事的基本情况 1、基本情况 本人陈彦，男，1963 年 1 月出生，中国国籍，无境外永久居留权，博士、 教授。1984 年 7 月至 1988 年 8 月，任安徽农业大学助教；1991 年 7 月至今，历 任安徽大学讲师、副教授、教授、副院长、博士生导师。2021 年 3 月至今 ...

证券代码：301108 证券简称：洁雅股份 公告编号：2025-027 铜陵洁雅生物科技股份有限公司 关于召开 2024 年年度股东大会的通知 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 铜陵洁雅生物科技股份有限公司（以下简称"公司"）第五届董事会第二十 六次会议审议通过了《关于召开 2024 年年度股东大会的议案》，决定于 2025 年 5 月 16 日（星期五）召开公司 2024 年年度股东大会，现将本次股东大会的有 关事项通知如下： 一、召开会议的基本情况 1. 股东大会届次：2024 年年度股东大会。 2. 股东大会的召集人：公司董事会。 3. 会议召开的合法、合规性：本次股东大会的召集和召开符合有关法律、 行政法规、部门规章、规范性文件及《公司章程》的规定和要求。 4. 会议召开的日期、时间： （1）现场会议召开时间：2025 年 5 月 16 日（星期五）下午 14:00。 （2）网络投票时间：2025 年 5 月 16 日（星期五）。 其中，通过深圳证券交易所交易系统进行网络投票的具体时间为 2025 年 5 月 16 日上午 9:15-9: ...

证券代码：301108 证券简称：洁雅股份 公告编号：2025-023 本公司及监事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 一、监事会会议召开情况 铜陵洁雅生物科技股份有限公司（以下简称"公司"）第五届监事会第二十 四次会议于 2025 年 4 月 23 日以现场结合通讯方式召开。会议通知于 2025 年 4 月 11 日以电子邮件方式发出。本次监事会应出席监事 3 人，实际出席监事 3 人 （其中监事俞彦诚先生以通讯表决的方式出席）。会议由公司监事会主席卢云凤 女士主持。本次监事会会议的召开符合《中华人民共和国公司法》等有关法律、 行政法规、部门规章、规范性文件及《公司章程》的规定。 二、监事会会议审议情况 经与会监事认真审议，形成如下决议： 1、审议通过《关于 2024 年度监事会工作报告的议案》 铜陵洁雅生物科技股份有限公司 第五届监事会第二十四次会议决议公告 具体内容详见公司同日披露于巨潮资讯网（http://www.cninfo.com.cn）的 《2024 年度监事会工作报告》。 表决结果：3 票同意，0 票反对，0 票弃权。 本议案尚需提交公司股东大 ...

铜陵洁雅生物科技股份有限公司（以下简称"公司"）第五届董事会第二十 六次会议于 2025 年 4 月 23 日以现场结合通讯方式召开，本次会议的通知已于 2025 年 4 月 11 日通过电子邮件的方式送达全体董事。本次会议应出席董事 9 人， 实际出席董事 9 人。本次会议由董事长兼总经理蔡英传先生主持，公司监事及高 级管理人员列席本次会议。本次董事会会议的召开符合《中华人民共和国公司法》 等有关法律、行政法规、部门规章、规范性文件及《公司章程》的规定。 二、董事会会议审议情况 证券代码：301108 证券简称：洁雅股份 公告编号：2025-022 铜陵洁雅生物科技股份有限公司 第五届董事会第二十六次会议决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 经与会董事认真审议，形成如下决议： 1、审议通过《关于〈2024 年度董事会工作报告〉的议案》 报告期内，董事会根据《公司法》《证券法》等法律法规、规范性文件及《公 司章程》相关规定，积极开展董事会各项工作。勤勉尽责履行职责和义务，保障 公司规范运作，促进公司持续健康、稳定的发 ...

2、本次利润分配预案尚需提交公司2024年年度股东大会审议。 证券代码：301108 证券简称：洁雅股份 公告编号：2025-024 铜陵洁雅生物科技股份有限公司 关于 2024 年度利润分配和资本公积金转增股本方案的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 一、审议程序 1、铜陵洁雅生物科技股份有限公司（以下简称"公司"）分别于2025年4 月11日召开第五届董事会2025年第三次独立董事专门会议、于2025年4月23日召 开第五届董事会第二十六次会议和第五届监事会第二十四次会议，全票审议通过 了《关于2024年度利润分配和资本公积金转增股本方案的议案》。 二、利润分配和资本公积金转增股本方案的基本情况 1、本次利润分配和资本公积金转增股本方案分配基准为2024年度。 2、经容诚会计师事务所（特殊普通合伙）审计，公司2024年度合并报表归 属于上市公司股东的净利润为19,464,754.70元，母公司净利润为19,778,515.46 元。根据《公司法》《公司章程》的规定，本年度不提取法定盈余公积。截至2024 年12月31日，公司合并报表未分配 ...

Financial Performance - In 2024, the net profit attributable to shareholders of the listed company decreased by 83.10% year-on-year, primarily due to intensified market competition and a significant decline in product gross margin [5]. - The company's operating revenue for 2024 was ¥547,450,447.64, a decrease of 12.07% compared to ¥622,587,051.34 in 2023 [5]. - The net profit attributable to shareholders for 2024 was ¥19,464,754.70, down 83.10% from ¥115,196,493.09 in 2023 [5]. - The net profit after deducting non-recurring gains and losses was -¥6,793,727.03 in 2024, a decline of 107.64% from ¥88,906,482.39 in 2023 [5]. - The net cash flow from operating activities for 2024 was ¥75,120,448.62, a decrease of 10.05% compared to ¥83,514,114.39 in 2023 [5]. - The total assets at the end of 2024 were ¥2,080,646,671.44, down 3.17% from ¥2,148,772,775.84 at the end of 2023 [5]. - The total net assets attributable to shareholders at the end of 2024 were ¥1,827,033,439.80, a decrease of 1.70% from ¥1,858,648,481.97 at the end of 2023 [5]. - The company reported a basic earnings per share of ¥0.24 for 2024, down 83.10% from ¥1.42 in 2023 [5]. - The overall gross margin for the reporting period was 19.63%, a decrease of 9.99 percentage points compared to the previous year [50]. - Revenue from the high-margin processing business was 7,150.52 million yuan, a decline of 44.21% year-on-year [50]. Market and Industry Trends - The domestic wet wipes industry experienced steady growth, but the trend of price competition led to an overall decline in industry gross margins [5]. - The global retail market for wet wipes reached $17.8 billion in 2023, with expectations to grow to $22.6 billion by 2028 [32]. - The rapid growth of the wet wipes market in China is driven by increased consumer hygiene awareness and a wider range of product applications [33]. - The Chinese wet wipes market reached a scale of 11.6 billion yuan in 2023, expected to grow to 14.6 billion yuan by 2028, with the fastest growth in wet toilet paper [34]. - The company ranks 8th among the top 15 wet wipes manufacturers in China based on sales from 2021 to 2023, with the top 15 accounting for approximately 50.09% of total sales in 2023 [40]. Strategic Initiatives - The company plans to increase efforts in developing foreign markets and deeply explore the market potential of existing customers to counteract domestic market challenges [5]. - The company is actively seeking market expansion opportunities and considering mergers and acquisitions as part of its growth strategy [5]. - The report indicates that the company is focusing on new product and technology development as part of its strategic initiatives [5]. - The company aims to transform from a traditional OEM factory to a professional ODM supply chain provider, enhancing its marketing capabilities and accelerating market expansion [101]. - The company plans to deepen its specialization in wet wipes, ensuring rapid growth in its core business while exploring new customers and business opportunities in cosmetics [101]. Research and Development - The company has developed a "zero preservative" and "pure water" formula series for baby wipes, emphasizing minimal additives [36]. - The company has a stable core technical team and holds 7 invention patents and 47 utility model patents in the wet wipes technology field [43]. - The R&D team is equipped with advanced domestic research and testing equipment, ensuring precise analysis of product safety and efficacy [46]. - The company has completed the development of a disinfectant wet wipe product that effectively removes 99% of bacteria, enhancing its competitive edge in the cleaning products industry [63]. - The company has successfully developed a green makeup remover wipe using natural fiber materials and no chemical additives, enhancing its brand image and market competitiveness [65]. Operational Risks and Challenges - The company anticipates a significant reduction in the present value of future cash flows from certain equipment due to underutilization of production capacity and declining gross margins, leading to increased impairment losses [5]. - The company faces significant risks from fluctuations in raw material prices, which constitute a high proportion of the main business costs, potentially impacting future profitability if prices continue to rise [103]. - The company has a high customer concentration risk, relying heavily on major clients like Woolworths and Procter & Gamble, which could adversely affect revenue and profits if these clients' procurement plans change [104]. - The company is exposed to exchange rate fluctuations, particularly as its export trade is mainly settled in USD, which could lead to significant uncertainty and risk [107]. - Rising labor costs due to labor shortages in China may increase product costs and impact profitability [108]. Corporate Governance and Compliance - The financial report is guaranteed to be true, accurate, and complete by the board of directors and senior management, ensuring accountability for any misrepresentation [4]. - The company emphasizes investor relations management, providing multiple channels for investor inquiries and ensuring transparency in information disclosure [121]. - The company has established a complete and independent business system, ensuring separation from the controlling shareholder in terms of assets, personnel, finance, and operations [122]. - The company has a strict information disclosure policy, ensuring timely and accurate communication of relevant information to shareholders [121]. - The company has established a sound corporate governance structure, ensuring that senior management is appointed without interference from shareholders [124]. Shareholder Relations and Profit Distribution - The board approved a profit distribution plan, proposing a cash dividend of 1 RMB per 10 shares (including tax) and a capital reserve conversion of 4 shares for every 10 shares [7]. - The company has implemented a clear profit distribution policy, ensuring that dividend standards and ratios are well-defined and approved through proper procedures [162]. - The company plans to distribute a cash dividend of 3.60 RMB per 10 shares, totaling 29,163,534.48 RMB (including tax) after adjusting for repurchased shares [163]. - The total cash dividend amount, including other methods, is 28,102,319.46 RMB, which accounts for 100% of the profit distribution total [165]. - The company will not issue bonus shares but will increase capital by 4 shares for every 10 shares held [167]. Environmental and Social Responsibility - The company has achieved ISO 14001:2015 environmental management system certification, demonstrating its commitment to environmental protection [180]. - The company has implemented various energy-saving measures, including the use of LED lights and solar power systems, to reduce carbon emissions [179]. - The company is committed to sustainable development by balancing corporate, social, and environmental responsibilities [180]. - Employee rights are safeguarded through compliance with labor laws, competitive compensation, and a focus on health and safety in the workplace [181]. - The company emphasizes the importance of environmental protection and adheres to national and local regulations regarding environmental laws [183].

Financial Performance - The company's revenue for Q1 2025 was ¥123,650,687.52, a decrease of 4.62% compared to ¥129,636,863.19 in the same period last year[6] - Net profit attributable to shareholders decreased by 27.61% to ¥10,062,741.65 from ¥13,901,683.51 year-on-year[6] - Basic and diluted earnings per share fell by 23.53% to ¥0.13 from ¥0.17 year-on-year[6] - Net profit for the period was CNY 10,049,939.90, down from CNY 13,872,350.05, reflecting a decline of approximately 27.5% year-over-year[23] - Operating profit decreased to CNY 9,818,421.55 from CNY 14,583,936.90, a decrease of about 32.5% year-over-year[23] - The total comprehensive income attributable to the parent company was 10,062,741.65, down from 13,901,683.51, indicating a decrease of about 27.5%[24] Cash Flow - The net cash flow from operating activities plummeted by 97.17% to ¥706,268.27, down from ¥24,938,524.30 in the previous year[6] - Cash inflow from operating activities totaled 169,830,905.09, down from 213,520,083.02, a decline of about 20.5%[27] - The net cash flow from operating activities was 706,268.27, significantly lower than 24,938,524.30 in the previous period, indicating a decrease of approximately 97.2%[27] - Cash inflow from investing activities was 873,876,401.49, an increase from 643,734,635.32, representing a growth of about 35.7%[27] - The net cash flow from investing activities was 382,954,686.05, compared to 20,610,864.36 in the previous period, showing a substantial increase[27] - The net increase in cash and cash equivalents was 384,074,597.63, up from 47,029,018.60, indicating a significant rise[27] Assets and Liabilities - Total assets at the end of Q1 2025 were ¥2,081,403,791.19, a slight increase of 0.04% from ¥2,080,646,671.44 at the end of the previous year[6] - Total liabilities decreased to CNY 243,399,436.20 from CNY 253,599,651.44, a reduction of approximately 4.0% year-over-year[20] - The company's equity attributable to shareholders rose by 0.60% to ¥1,838,003,576.54 from ¥1,827,033,439.80 at the end of the previous year[6] - The company's equity attributable to shareholders increased to CNY 1,838,003,576.54 from CNY 1,827,033,439.80, reflecting a growth of about 0.6% year-over-year[20] Shareholder Information - The total number of common shareholders at the end of the reporting period is 7,273[12] - The largest shareholder, Cai Yingchuan, holds 53.42% of the shares, totaling 42,946,052 shares[12] - The second-largest shareholder, Tongling Mingyuan Investment Management Co., holds 10.40% of the shares, totaling 8,360,000 shares[12] - The top three shareholders account for 66.51% of the total shares[12] - The total number of shares held by the top ten unrestricted shareholders is 12,000,000[13] Expenses and Investments - The company experienced a 48.70% reduction in selling expenses, which amounted to ¥1,308,304.10 compared to ¥2,550,541.47 in the previous year[9] - Research and development expenses were CNY 5,416,839.72, slightly up from CNY 5,275,852.08, indicating a focus on innovation[23] - The company reported a financial income of CNY 1,580,408.69, down from CNY 2,309,925.20, a decrease of approximately 31.5% year-over-year[23] - The company reported a significant increase of 155.02% in cash received from investment income, totaling ¥14,586,905.91 compared to ¥5,719,989.30 last year[10] - The company reported a 2652.73% increase in asset disposal income, reaching ¥167,696.03 compared to ¥6,092.00 in the previous year[9] Future Plans - The company plans to maintain its current strategies without any new product launches or market expansions reported in this period[17] - The company plans to enhance market expansion strategies and invest in new technologies to drive future growth[22]

洁雅股份（301108）公告，2025年第一季度营业收入1.24亿元，同比下降4.62%。净利润1006.27万元， 同比下降27.61%。 ...

证券代码：301108 证券简称：洁雅股份 公告编号：2025-021 铜陵洁雅生物科技股份有限公司 关于会计政策变更的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 2024年12月6日，财政部颁布了《企业会计准则解释第18号》（财会〔2024〕 24号），该解释规定自引发之日起施行，允许企业自发布年度提前执行。 公司根据上述文件规定的起始日，开始执行上述新会计政策。 2、变更前采用的会计政策 本次会计政策变更前，公司执行财政部发布的《企业会计准则——基本准则》 和各项具体会计准则、企业会计准则应用指南、企业会计准则解释公告以及其他 相关规定。 3、变更后采用的会计政策 本次会计政策变更后，公司将执行《企业会计准则解释第18号》的相关规定。 特别提示：本次会计政策变更不会对公司当期财务状况、经营成果和现金 流量产生影响，不涉及以前年度的追溯调整，不存在损害公司及股东利益的情 形。 铜陵洁雅生物科技股份有限公司（以下简称"公司"）根据中华人民共和国 财政部（以下简称"财政部"）颁布的《企业会计准则解释第18号》（财会〔2024〕 24号，以下简称《准则解 ...